RT Journal Article
SR Electronic
T1 Angiotensin-converting enzyme (<em>ACE1, ACE2</em>) gene variants are associated with COVID19 severity depending on the hypertension status
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.11.20128033
DO 10.1101/2020.06.11.20128033
A1 Gómez, Juan
A1 Albaiceta, Guillermo M
A1 García-Clemente, Marta
A1 López-Larrea, Carlos
A1 Amado-Rodríguez, Laura
A1 Hermida, Tamara
A1 Enriquez, Ana I.
A1 Herrero, Pablo
A1 Melón, Santiago
A1 Alvarez-Argüelles, Marta E.
A1 Rojo-Alba, Susana
A1 Leal-Negredo, Alvaro
A1 Cuesta-Llavona, Elías
A1 Alvarez, Victoria
A1 Lorca, Rebeca
A1 Coto, Eliecer
YR 2020
UL http://medrxiv.org/content/early/2020/06/12/2020.06.11.20128033.abstract
AB Background The Angiotensin system is implicated in the pathogenesis of COVID19. First, ACE2 is the cellular receptor for SARS-COv-2, and expression of the ACE2 gene could regulate the individual’s susceptibility to infection. In addition, the balance between ACE1 and ACE activity has been implicated in the pathogenesis of respiratory diseases and could play a role in the severity of COVID19. Functional ACE1/ACE2 gene polymorphisms have been associated with the risk of cardiovascular and pulmonary diseases, and could thus also contribute to the outcome of COVID19.Methods We studied 204 COVID19 patients (137 non-severe and 67severe-ICU cases) and 536 age-matched controls. The ACE1 insertion/deletion and ACE2rs2285666 polymorphism were determined. Variables frequencies were compared between the groups by logistic regression. We also sequenced the ACE2 coding nucleotides in a group of patients.Results Severe COVID19 was associated with hypertension male gender (p&lt;0.001), hypertension (p=0.006), hypercholesterolaemia (p=0.046), and the ACE1-DD genotype (p=0.049). In the multiple logistic regression hypertension (p=0.02, OR=2.26, 95%CI=1.12-4.63) and male gender (p=0.002; OR=3.15, 95%CI=1.56-6.66) remained as independent significant predictors of severity. The ACE2 polymorphism was not associated with the disease outcome. The ACE2 sequencing showed no coding sequence variants that could explain an increased risk of developing COVID19.Conclusions Adverse outcome of COVID19 was associated with male gender, hypertension, hypercholesterolemia and the ACE1 genotype. The ACE1-I/D was a significant risk factor for severe COVID19, but the effect was dependent on the hypertensive status.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a grant from the Spanish Plan Nacional de I+D+I Ministerio de Economia y Competitividad and the European FEDER, grant ISCIII-Red de Investigacion Renal-REDINREN RD16/9/5 (EC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:COMITE ETICO DEL HOSPITAL CENTRAL DE ASTURIASAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDATA ARE AVAILABLE UPON REQUEST TO THE CA